Circulating cell-free DNA content as blood based biomarker in endometrial cancer

BACKGROUND: Altered circulating cell-free DNA (cfDNA) levels are related to cancer development and aggressiveness. Up to now, very few studies have been performed for evaluating cfDNA content in endometrial cancer (EC). METHODS: First, we measured cfDNA release in blood serum of EC cancer patients c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicchillitti, Lucia, Corrado, Giacomo, De Angeli, Martina, Mancini, Emanuela, Baiocco, Ermelinda, Patrizi, Lodovico, Zampa, Ashanti, Merola, Roberta, Martayan, Aline, Conti, Laura, Piaggio, Giulia, Vizza, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777767/
https://www.ncbi.nlm.nih.gov/pubmed/29383155
http://dx.doi.org/10.18632/oncotarget.23247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777767/
https://www.ncbi.nlm.nih.gov/pubmed/29383155
http://dx.doi.org/10.18632/oncotarget.23247

Ejemplares similares